TechNavio's analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus developing resistance to the drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Hepatitis C Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hepatitis C Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and Vertex Pharmaceuticals Ltd.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
Table of Contents
Table of Contents
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1. Roche Holding Ltd.
15.2. Merck & Co. Inc.
15.3. GlaxoSmithKline plc
15.4. Vertex Pharmaceuticals Ltd.
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Hepatitis C Drugs Market 2011-2015 (US$ billion)
Exhibit 2: Global Hepatitis C Drugs Market Segmentation by Therapy 2011
Exhibit 3: Global Hepatitis C Drugs Market by Geographical Segmentation 2011
Exhibit 4: Hepatitis C Infection by Source 2011
Exhibit 5: Global Hepatitis C Drugs Market by Vendor Segmentation 2011
Global Hepatitis C Drugs Market 2011-2015 published by Infiniti Research Limited (Technavio) in May 11, 2012. This report consists of Pages: 37 and the price starts from US $ 1500.